Skip to content

Clinical trials

Lung Diseases trials in Chile

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Diseases Country / region: Chile Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20081
20111
20131
20143
20162
20181
20193
20231
20242
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting3
Recruiting2
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca8
Bayer2
United Therapeutics2
Upstream Bio Inc.2
Novartis Pharmaceuticals1
Nuvalent Inc.1
Population Health Research Institute1
Seagen, a wholly owned subsidiary of Pfizer1
Taiho Oncology, Inc.1
Universidad de Santiago de Chile1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Diseases20
Respiratory Tract Diseases11
Bronchial Diseases9
Asthma8
Lung Diseases, Obstructive7
Pulmonary Disease, Chronic Obstructive6
Carcinoma, Non-Small-Cell Lung3
Cardiovascular Diseases3
Bronchitis, Chronic2
Connective Tissue Diseases2

Trials

Showing 1 to 20 of 20. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.